Alembic Pharmaceuticals approval marks a significant milestone for ear infection treatment with USFDA’s final approval.
Author: Oliver Edwards
Finn Oliver Edwards: Finn, a pediatric nurse, shares child health tips, parenting advice, and preventive measures for common childhood illnesses.
Cancer drug price cuts: Are they the best deal for patients?
Cancer drug price cuts are set to provide significant savings for patients starting November 9.
Karnataka Medicine Pricing: Clear Rules for MRP Disclosure
Karnataka medicine pricing regulations require landing price and MRP disclosure on bills starting November 1, ensuring transparency for consumers.
Prostate Cancer Drug Approval: Hengrui Pharma’s New Hope
Prostate cancer drug approval has been achieved by Hengrui Pharma, promising new treatment options for patients in Europe.
Deep Health AI India Secures Smart Debt Acquisition Deal
Deep Health AI India has approved a ₹10.35 crore debt acquisition from Kshitij Polyline, marking a significant financial move.
Healthcare stocks slide: The Worst Impact on Investors
Healthcare stocks slide as SC raises concerns about pricing gaps.
Apixaban Oral Suspension: Safe and Proven FDA Approval
Apixaban Oral Suspension receives tentative FDA approval, a significant step for Lupin in the pharmaceutical industry.
FDA Approval Everolimus: Is It the Best Option for Patients?
FDA approval everolimus brings new hope for patients seeking treatment options.
IV Fluid Price Orders: Safe Changes by NPPA
IV fluid price orders are revised by NPPA, ensuring better healthcare access with new pricing strategies.
Is the Nivolumab Biosimilar Launch a Smart Move for India?
Nivolumab biosimilar launch marks a significant step in cancer treatment in India, offering new hope for patients.